ORIGINAL RESEARCH article
Front. Neurosci.
Sec. Translational Neuroscience
Serum Otolin-1 and Otoconin-90 Are Not Elevated in Vestibular Migraine: A Preliminary Case-Control Study
Provisionally accepted
- 1Department of Neurology, Ningbo No.2 Hospital, Ningbo, China
- 2School of Medicine, Shaoxing University, Shaoxing, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Abstract: Objective: Vestibular migraine (VM) is a common cause of episodic vertigo but lacks objective diagnostic biomarkers. The symptomatic overlap of VM with benign paroxysmal positional vertigo (BPPV) and Meniere's disease (MD) complicates differential diagnosis. Given that elevated serum Otolin-1 and Otoconin-90 (OC90) levels are established biomarkers in BPPV and MD, this study aimed to determine whether these otoconia-derived proteins are also altered in VM. Methods: In this case-control study, 40 patients with definite VM and 143 age- and sex-matched healthy controls were included. Serum samples were collected during the interictal period. Otolin-1 and OC90 levels were quantified using enzyme-linked immunosorbent assays. Results: No significant differences were found in serum levels of Otolin-1 and OC90 between groups. The median (IQR) Otolin-1 level was 215.5 pg/mL (127.5-314.9) in the VM group versus 200.6 pg/mL (127.7-284.2) in controls (Cliff’s δ = 0.08, p = 0.526). Similarly, the median (IQR) OC90 level was 39.8 ng/mL (29.4-60.8) compared to 32.7 ng/mL (27.9-77.9) in controls (Cliff’s δ = -0.07, p = 0.659). No correlations were observed between protein levels and clinical features. However, within the VM group, serum Otolin-1 levels were highest within one-week post-attack and declined thereafter, showing a significant negative correlation with time (r = -0.372, p = 0.018). A similar phase-dependent pattern was observed for OC90 levels across the VM subgroups (p = 0.017), though without a significant correlation with continuous time. Conclusion: These preliminary findings indicate that serum Otolin-1 and OC90 levels are not altered in patients with VM compared to healthy controls. Exploratory analysis revealed a phase-dependent decrease in Otolin-1 within the VM group post-attack. These results argue against significant structural damage to otoconia in VM and support a central/functional pathophysiology. While not positive diagnostic biomarkers, normal levels of these proteins may provide negative evidence to aid in differentiating VM from BPPV or MD, pending future validation.
Keywords: biomarker, differential diagnosis, otoconia, otoconin-90, otolin-1, vestibular migraine
Received: 16 Dec 2025; Accepted: 09 Feb 2026.
Copyright: © 2026 Li, Fan, Li, Liu, Guan, Fan and Wu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Weinv Fan
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.